Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy
Titel:
Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy
Auteur:
Liao, Cheng Hsu, Jonathan Kim, Yong Hu, Dong-Qing Xu, Daigen Zhang, Jun Pashine, Achal Menke, John Whittard, Toni Romero, Natasha Truitt, Theresa Slade, Michelle Lukacs, Christine Hermann, Johannes Zhou, Mingyan Lucas, Matthew Narula, Satwant DeMartino, Julie Tan, Seng-Lai